UniProt ID | TLR4_HUMAN | |
---|---|---|
UniProt AC | O00206 | |
Protein Name | Toll-like receptor 4 | |
Gene Name | TLR4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 839 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Early endosome . Upon complex formation with CD36 and TLR6, internalized through dynamin-dependent endocytosis (PubMed:20037584). Colocalizes with RFTN1 at cell membrane and then together with RFT |
|
Protein Description | Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). [PubMed: 27022195 Acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response] | |
Protein Sequence | MMSASRLAGTLIPAMAFLSCVRPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNITCQMNKTIIGVSVLSVLVVSVVAVLVYKFYFHLMLLAGCIKYGRGENIYDAFVIYSSQDEDWVRNELVKNLEEGVPPFQLCLHYRDFIPGVAIAANIIHEGFHKSRKVIVVVSQHFIQSRWCIFEYEIAQTWQFLSSRAGIIFIVLQKVEKTLLRQQVELYRLLSRNTYLEWEDSVLGRHIFWRRLRKALLDGKSWNPEGTVGTGCNWQEATSI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
35 | N-linked_Glycosylation | PCVEVVPNITYQCME CCEEECCCCEEEEEE | 27.85 | 11706042 | |
173 | N-linked_Glycosylation | KLPEYFSNLTNLEHL CCHHHHHCCCCCHHC | 40.77 | 11706042 | |
175 | Phosphorylation | PEYFSNLTNLEHLDL HHHHHCCCCCHHCCC | 41.84 | 16786156 | |
191 | Phosphorylation | SNKIQSIYCTDLRVL CCCCCEEEECCHHHH | 8.44 | 22210691 | |
193 | Phosphorylation | KIQSIYCTDLRVLHQ CCCEEEECCHHHHHH | 22.54 | 22210691 | |
205 | N-linked_Glycosylation | LHQMPLLNLSLDLSL HHHCCCCCEEECCCC | 34.95 | 11706042 | |
282 | N-linked_Glycosylation | SALEGLCNLTIEEFR HHHHHHHCCCHHHHH | 45.31 | 11706042 | |
309 | N-linked_Glycosylation | DLFNCLTNVSSFSLV HHHHHHHCCCCCEEE | 20.80 | 11706042 | |
357 | Phosphorylation | LKSLKRLTFTSNKGG ECCCEEEEEECCCCC | 28.97 | 30206219 | |
359 | Phosphorylation | SLKRLTFTSNKGGNA CCEEEEEECCCCCCC | 26.59 | 30206219 | |
360 | Phosphorylation | LKRLTFTSNKGGNAF CEEEEEECCCCCCCC | 32.14 | 30206219 | |
386 | Phosphorylation | DLSRNGLSFKGCCSQ CCCCCCCCCCCCCCC | 26.72 | 24719451 | |
407 | Phosphorylation | SLKYLDLSFNGVITM CCEECEEEECCEEEE | 19.14 | 26074081 | |
497 | N-linked_Glycosylation | DIFTELRNLTFLDLS HHHHHHHCCCCCCCC | 56.93 | 11706042 | |
512 | Phosphorylation | QCQLEQLSPTAFNSL HHCHHHCCHHHHHCC | 21.65 | 26074081 | |
514 | Phosphorylation | QLEQLSPTAFNSLSS CHHHCCHHHHHCCCC | 40.27 | 26074081 | |
518 | Phosphorylation | LSPTAFNSLSSLQVL CCHHHHHCCCCCEEE | 24.15 | 26074081 | |
520 | Phosphorylation | PTAFNSLSSLQVLNM HHHHHCCCCCEEECC | 28.90 | 26074081 | |
521 | Phosphorylation | TAFNSLSSLQVLNMS HHHHCCCCCEEECCC | 28.28 | 26074081 | |
526 | N-linked_Glycosylation | LSSLQVLNMSHNNFF CCCCEEECCCCCCCC | 30.93 | 11706042 | |
526 | N-linked_Glycosylation | LSSLQVLNMSHNNFF CCCCEEECCCCCCCC | 30.93 | 11706042 | |
528 | Phosphorylation | SLQVLNMSHNNFFSL CCEEECCCCCCCCCC | 23.22 | 26074081 | |
551 | Phosphorylation | NSLQVLDYSLNHIMT CHHHHHHHHHHHHHC | 15.76 | 22210691 | |
552 | Phosphorylation | SLQVLDYSLNHIMTS HHHHHHHHHHHHHCC | 23.51 | 22210691 | |
558 | Phosphorylation | YSLNHIMTSKKQELQ HHHHHHHCCCHHHHH | 36.47 | 22210691 | |
575 | N-linked_Glycosylation | PSSLAFLNLTQNDFA CCCCHHHCCCCCCCE | 34.29 | 11706042 | |
575 | N-linked_Glycosylation | PSSLAFLNLTQNDFA CCCCHHHCCCCCCCE | 34.29 | 11706042 | |
624 | N-linked_Glycosylation | GMPVLSLNITCQMNK CCEEEEEEEEEECCC | 24.93 | 11706042 | |
630 | N-linked_Glycosylation | LNITCQMNKTIIGVS EEEEEECCCCCCCHH | 16.67 | UniProtKB CARBOHYD | |
674 | Phosphorylation | YGRGENIYDAFVIYS HCCCCCEEEEEEEEC | 16.89 | 22817900 | |
680 | Phosphorylation | IYDAFVIYSSQDEDW EEEEEEEECCCCCHH | 9.29 | 22817900 | |
730 | Phosphorylation | IHEGFHKSRKVIVVV HHCCCCCCCEEEEEE | 28.85 | 20058876 | |
738 | Phosphorylation | RKVIVVVSQHFIQSR CEEEEEEEHHHHHHC | 13.31 | - | |
790 | Phosphorylation | VELYRLLSRNTYLEW HHHHHHHHCCCCCCC | 28.24 | 20557879 | |
800 | Phosphorylation | TYLEWEDSVLGRHIF CCCCCHHHHHHHHHH | 14.02 | - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TLR4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00821 | Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of ret | |||||
OMIM Disease | ||||||
611488 | Macular degeneration, age-related, 10 (ARMD10) | |||||
Kegg Drug | ||||||
D04043 | Eritoran tetrasodium (USAN); E5564 | |||||
D09573 | Eritoran sodium (JAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex."; Park B.S., Song D.H., Kim H.M., Choi B.-S., Lee H., Lee J.-O.; Nature 458:1191-1195(2009). Cited for: X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 27-631 IN COMPLEX WITH LY96AND LIPOPOLYSACCHARIDE, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-173;ASN-205; ASN-497 AND ASN-526 AND ASN-575. | |
"Crystal structure of the TLR4-MD-2 complex with bound endotoxinantagonist Eritoran."; Kim H.M., Park B.S., Kim J.-I., Kim S.E., Lee J., Oh S.C.,Enkhbayar P., Matsushima N., Lee H., Yoo O.J., Lee J.-O.; Cell 130:906-917(2007). Cited for: X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 27-228, DISULFIDE BONDS, ANDGLYCOSYLATION AT ASN-35; ASN-173 AND ASN-205. | |
"MD-2 and TLR4 N-linked glycosylations are important for a functionallipopolysaccharide receptor."; da Silva Correia J., Ulevitch R.J.; J. Biol. Chem. 277:1845-1854(2002). Cited for: GLYCOSYLATION AT ASN-35; ASN-173; ASN-205; ASN-282; ASN-309; ASN-497;ASN-526; ASN-575 AND ASN-624, AND MUTAGENESIS OF ASN-526 AND ASN-575. |